Labitad, Rhen Heart L.

HRN: 21-93-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2022
CEFUROXIME 750MG (VIAL)
09/24/2022
10/01/2022
IV
170mg
Q8
AGE, PCAP
Waiting Final Action 
03/31/2024
CEFTRIAXONE 1G (VIAL)
03/31/2024
04/07/2024
IV DRIP
900mg
Q24
PCAP C
Waiting Final Action 
04/05/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
04/05/2024
04/11/2024
PO
3ml
BID
PCAP C
Waiting Final Action 
04/08/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/08/2024
04/13/2024
ORAL
2 Ml
Every 6 Hours
Empiric
Waiting Final Action 
07/21/2024
OXACILLIN 500MG (VIAL)
07/21/2024
07/27/2024
IV
395mg
Q6
Impetigo
Waiting Final Action 
07/21/2024
MUPIROCIN 2%, 15G (TUBE)
07/21/2024
07/27/2024
TOPICAL
Pea Sized
BID
Empitigo
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: